Mazzacco Catherine has filed 8 insider transactions across 2 companies since March 2023.
Most recent transaction: a gift of 37492 shares of Sight Sciences, Inc. ($SGHT) on September 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | Sight Sciences, Inc. | $SGHT | Mazzacco Catherine | Not found | G | Common Stock | 37492 | $0.00 | 41,015.0000 | 51,332,694 | 47.76% | 0.07% |
| June 30, 2025 | Krystal Biotech, Inc. | $KRYS | Mazzacco Catherine | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 29,740,000 | 9999.99% | 0.02% |
| June 5, 2025 | Sight Sciences, Inc. | $SGHT | Mazzacco Catherine | Not found | A | Common Stock | 30952 | $0.00 | 78,507.0000 | 51,332,694 | 65.09% | 0.06% |
| June 30, 2024 | Krystal Biotech, Inc. | $KRYS | Mazzacco Catherine | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 27,752,000 | 9999.99% | 0.02% |
| June 6, 2024 | Sight Sciences, Inc. | $SGHT | Mazzacco Catherine | Not found | A | Common Stock | 17366 | $0.00 | 47,555.0000 | 0 | 57.52% | 0.00% |
| June 30, 2023 | Krystal Biotech, Inc. | $KRYS | Mazzacco Catherine | Director | A | Stock Option (Right to Buy) | 2180 | $0.00 | 2,180.0000 | 25,492,000 | 9999.99% | 0.01% |
| June 8, 2023 | Sight Sciences, Inc. | $SGHT | Mazzacco Catherine | Director | A | Common Stock | 30189 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| March 31, 2023 | Krystal Biotech, Inc. | $KRYS | Mazzacco Catherine | Director | A | Stock Option (Right to Buy) | 13600 | $0.00 | 13,600.0000 | 25,492,000 | 9999.99% | 0.05% |